Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cts (CTS) Asset Writedowns and Impairment (2019 - 2024)

Cts (CTS) has disclosed Asset Writedowns and Impairment for 2 consecutive years, with $1.3 million as the latest value for Q2 2023.

  • For the quarter ending Q2 2023, Asset Writedowns and Impairment changed N/A year-over-year to $1.3 million, compared with a TTM value of $1.3 million through Sep 2024, changed N/A, and an annual FY2020 reading of $1.0 million, changed N/A over the prior year.
  • Asset Writedowns and Impairment was $1.3 million for Q2 2023 at Cts, up from $1.0 million in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $1.3 million in Q2 2023 and bottomed at $1.0 million in Q1 2020.